Tarsus Pharmaceuticals, Inc. (TARS) NASDAQ
57.41
-1.52(-2.58%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
57.41
-1.52(-2.58%)
Currency In USD
| Market Cap | 3.42B |
| Enterprise Value | 3.33B |
| P/E Ratio | -51.1 |
| PEG Ratio | -0.5 |
| Price/Sales Ratio | 4.62 |
| Price/Book Ratio | 7.07 |
| Enterprise/Revenue | 4.59 |
| Enterprise/EBITDA | -62.8 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.09 |
| Operating Margin | -0.09 |
| Return On Assets | -0.08 |
| Return On Equity | -0.14 |
| Revenue | 451.36M |
| Revenue/Share | 12.46 |
| Gross Profit | 420.68M |
| EBITDA | -53.61M |
| Net Income | -66.42M |
| Diluted EPS | -1.59 |
| Total Cash | 388.73M |
| Total Cash/Share | 9.05 |
| Total Debt | 88.68M |
| Total Debt/Equity | 0.25 |
| Current Ratio | 3.74 |
| Book Value Per Share | 8.12 |
| 52-Week Change | 30.92 |
| 52-Week High | 85.25 |
| 52-Week Low | 38.51 |
| Moving Average 50 Days | 65.02 |
| Moving Average 200 Days | 67.98 |
| Average Volume | 595,585 |
| Shares Outstanding | 43.02M |
| % Held by Institutions | 105.51 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |